Innovative 3-dimensional optoacoustic imaging for safe breast cancer screening

Project description

Safe 3D imaging system for breast tissue

Breast cancer is the second leading type of cancer in women worldwide. In 2018, 2 million new cases were recorded and over 620 000 deaths. Mass screening programmes and early diagnosis are based on mammography. However, this produces harmful side effects and false-positive results, requiring additional screenings. A new, more safe and precise method is a necessity. The EU-funded LOUISA 3D project will provide an innovative, non-invasive clinical breast imaging system using optoacoustic technology. This will produce scans at different wavelengths to visualise multiple features of the tissue, without patient discomfort. Project work will enable safe, precise detection and diagnostics of cancer and vascular diseases.

Fields of science

• medical and health sciences › clinical medicine › angiology › vascular diseases
• medical and health sciences › clinical medicine › oncology › breast cancer
• natural sciences › physical sciences › optics › laser physics
• natural sciences › physical sciences › acoustics › ultrasound

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

TOMOWAVE SYSTEMS LTD

Net EU contribution

€ 50 000,00

Address

Unit 6 Queen's Yard White Post Lane
E9 5EN London
United Kingdom

Region

London › Inner London — East › Tower Hamlets

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 21 429,00